EPILEPTIC ENCEPHALOPATHY
Clinical trials for EPILEPTIC ENCEPHALOPATHY explained in plain language.
Never miss a new study
Get alerted when new EPILEPTIC ENCEPHALOPATHY trials appear
Sign up with your email to follow new studies for EPILEPTIC ENCEPHALOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug tested to calm electrical storms in Children's brains
Disease control CompletedThis study tested whether an experimental drug called NBI-827104 could help children with a rare, severe form of epilepsy called epileptic encephalopathy with continuous spike-and-wave during sleep. Twenty-four children took the drug or a placebo daily for 13 weeks while research…
Matched conditions: EPILEPTIC ENCEPHALOPATHY
Phase: PHASE2 • Sponsor: Neurocrine Biosciences • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Hope for Hard-to-Treat seizures: Long-Term drug safety confirmed
Disease control CompletedThis study aimed to understand the long-term safety of a medication called ZX008 (fenfluramine) when used alongside other treatments for severe, rare seizure disorders like Dravet and Lennox-Gastaut syndromes. It involved 412 patients who had already benefited from the drug in ea…
Matched conditions: EPILEPTIC ENCEPHALOPATHY
Phase: PHASE3 • Sponsor: Zogenix, Inc. • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
Scientists test Easier-to-Swallow liquid for severe childhood epilepsy
Knowledge-focused CompletedThis study tested how the body absorbs a new liquid form of the drug stiripentol, used for a severe form of childhood epilepsy called Dravet syndrome. Researchers compared it to the standard capsule form in 24 healthy adults to see if they work similarly. The goal is to provide a…
Matched conditions: EPILEPTIC ENCEPHALOPATHY
Phase: PHASE1 • Sponsor: Biocodex • Aim: Knowledge-focused
Last updated Mar 16, 2026 15:24 UTC